Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Reduces cravings for junk food and sugar by regulating blood sugar
India has the worlds third largest number of people with obesity
Outside the cost of the treatment, Aon observed a seven-percentage point improvement in medical spend growth for GLP-1 users in the second year
Use in type 1 diabetes: Evidence and clinical rationale While randomised controlled trials, such as SURPASS-T1D-1 (clinicaltrials.gov identifier NCT06914895) and SURPASS-T1D-2 (NCT06962280), are ongoing, growing real-world evidence suggests that tirzepatide may serve as an effective adjunct to insulin in people with obesity and type 1 diabetes
US$ 29.92
US$ 22.43
US$ 26.32
US$ 28.46
US$ 22.34
US$ 23.98
